|
ZNF280B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.698800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.501200E-01 |
| Normal-vs-Stage2 |
7.218400E-01 |
| Normal-vs-Stage3 |
5.262400E-01 |
| Normal-vs-Stage4 |
8.338000E-01 |
| Stage1-vs-Stage2 |
7.903400E-01 |
| Stage1-vs-Stage3 |
6.267400E-01 |
| Stage1-vs-Stage4 |
9.231800E-01 |
| Stage2-vs-Stage3 |
9.860600E-01 |
| Stage2-vs-Stage4 |
8.740000E-01 |
| Stage3-vs-Stage4 |
8.127200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.399400E-01 |
| Normal-vs-AfricanAmerican |
1.138590E-01 |
| Normal-vs-Asian |
5.409600E-02 |
| Caucasian-vs-AfricanAmerican |
8.704000E-02 |
| Caucasian-vs-Asian |
5.083400E-03 |
| AfricanAmerican-vs-Asian |
2.610200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.635400E-01 |
| Normal-vs-Female |
6.412800E-01 |
| Male-vs-Female |
7.901000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.871000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.420600E-01 |
| Normal-vs-Age(61-80Yrs) |
9.307200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.454000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.054600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.714200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.834400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.611000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.886200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.670000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.015800E-01 |
| Normal-vs-Grade 2 |
4.789800E-01 |
| Normal-vs-Grade 3 |
1.749200E-01 |
| Normal-vs-Grade 4 |
3.652600E-01 |
| Grade 1-vs-Grade 2 |
9.938200E-01 |
| Grade 1-vs-Grade 3 |
6.940600E-01 |
| Grade 1-vs-Grade 4 |
7.194000E-01 |
| Grade 2-vs-Grade 3 |
3.598500E-02 |
| Grade 2-vs-Grade 4 |
1.438600E-01 |
| Grade 3-vs-Grade 4 |
9.162400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.841700E-03 |
| Normal-vs-ccB subtype |
8.238700E-04 |
| ccA subtype-vs-ccB subtype |
7.9231998739715E-10 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.921400E-01 |
| Normal-vs-N1 |
1.752560E-01 |
| N0-vs-N1 |
1.790970E-01 |
|
|
